Ring Therapeutics

Revolutionizing Medicine with Commensal Viruses

Ring Therapeutics was founded in 2017, is headquartered in Cambridge, United States, lists 11–50 employees, and has $203.5M in recorded funding across 2 rounds.

Employees
11–50
Founded
2017
Business Model
B2B
Website
ringtx.com
Total Funding
$203.5M
Last Round
$86.5M Series CMar 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Ring Therapeutics, founded by Flagship Pioneering in 2017 and based in Cambridge, Massachusetts, is developing a novel class of gene delivery vectors called Anellovectors, derived from anelloviruses — ubiquitous, non-pathogenic commensal viruses found throughout the human virome. The company's platform unites vector-based technology capable of tissue and cellular tropism, payload versatility, and redosability with a scalable, modular manufacturing process, aiming to create programmable genetic medicines with broader therapeutic windows and reduced immune resistance than existing gene therapy vectors.

Summary

Ring Therapeutics is a Biotech company based in Cambridge, United States, founded in 2017. It lists 11–50 employees. It has raised $203.5M in total across 2 rounds, most recently a $86.5M Series C round in Mar 2023. Investors include Flagship Pioneering, Alexandria Venture Investments and Altitude Life Science Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMar 2023
$86.5M

Sign up to see all 2 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ring Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ring-therapeutics"><img src="https://indexed.vc/api/badge/company/ring-therapeutics" alt="Ring Therapeutics on Indexed.vc" width="260" height="76" /></a>